CTAS vs PODD · P/E 51, rev $10.34B vs P/E 34, rev $2.07B
Cintas Corporation (CTAS) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CTAS revenue for 2025-05-31 was $10.34B. Net income was $1.81B. Revenue was up 7.7% from 2024-05-31 to 2025-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CTAS and PODD stock pages for the full models.
Not investment advice.